.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Chronic Health is stocked at 42 licensed dispensaries across Arizona, with the deepest coverage in Phoenix, Mesa, Tucson, El Mirage, and Kingman. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Chronic Health concentrated 66.16% of sales in Topical with a 0.56% year-over-year gain and an 11.92% month-over-month rise, while Tincture & Sublingual held 33.84% share with a -25.09% year-over-year decline but a 26.40% month-over-month rebound. Despite an overall brand sales year-over-year decline of -9.88% and an average price drop of -3.93%, Topical’s higher average price at $22.64 versus $12.97 in Tincture & Sublingual indicates mix is tilting toward the higher-priced segment as monthly demand accelerates in both categories.
Category momentum positions Chronic Health to lean into Topical leadership, where it holds rank 2 in Topical in Arizona, as the 11.92% month-over-month gain in Topical and the 26.40% month-over-month lift in Tincture & Sublingual suggest short-term recapture of volume even as Tincture & Sublingual lags year-over-year by -25.09%. With total 24-month sales down -4.68% and Topical’s year-over-year change at 0.56% versus brand-wide -9.88%, the data imply a strategy to defend and extend Topical share while selectively pruning or repositioning Tincture & Sublingual to prevent further drag on brand-level trajectory.
Competitive Landscape
Chronic Health sits at rank #2 in AZ Topical in July 2026, unchanged year over year at #2, after improving from #3 three months earlier and having previously peaked at #1 in March 2025; meanwhile, Drip Oils + Extracts holds #1 with an 18.3% year-over-year sales increase and Gramz climbed from #8 to #4 with 280.2% year-over-year growth, while iLava slipped from #4 to #5 with a 34.7% decline. The combination of stability at #2 and a recent quarter-on-quarter rise from #3 indicates Chronic Health is defending share against an accelerating mid-pack challenger and a steady leader, implying the brand’s trajectory is consolidation near the top rather than immediate regain of the #1 peak absent a step-change in velocity.
Notable Products
CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) posted the standout move in July 2026 with a 46.2% month-over-month gain into rank 3, while Indica THC Glycerin Tincture (100mg THC, 1oz) rose 29.0% to rank 1. CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) advanced 20.7% yet held rank 2, and the CBD/THC 1:1 Glycerin Tincture grew 23.4% at rank 4, indicating Tincture & Sublingual holds three of the top four positions even as Topical logged the month’s biggest surge. With Topical also adding a 32.7% lift via the CBD/THC 1:1 Pain Relief Roll-On (50mg CBD, 50mg THC) at a shared rank 8 and a modest 4.6% increase for the 350mg CBD/THC ointment at rank 5, the mix tilts toward pain-management formats despite tinctures retaining the leadership tier. The pattern implies Chronic Health is consolidating around a two-pillar strategy where Tincture & Sublingual anchors share and Topical captures incremental demand, setting up near-term emphasis on symptom-specific SKUs over breadth expansion.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
